DCF — MERCY MEDICAL CENTER-DES MOINES
Enterprise Value: $-623.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-623.2M
Enterprise Value
$-206.1M
PV of Cash Flows
$-417.2M
PV of Terminal Value
$-671.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $654.8M | $-34.0M | -5.0% | $-61.7M | $-56.1M |
| Year 2 | $674.5M | $-28.2M | -4.0% | $-56.8M | $-46.9M |
| Year 3 | $694.7M | $-22.1M | -3.0% | $-51.5M | $-38.7M |
| Year 4 | $715.5M | $-19.2M | -3.0% | $-49.5M | $-33.8M |
| Year 5 | $737.0M | $-18.0M | -2.0% | $-49.2M | $-30.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-623.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$635.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05686941058909915
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5